This HTML5 document contains 128 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1111/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q41434863
rdf:type
wikibase:Item
schema:description
article scientific tudományos cikk vetenskaplig artikel 2015 nî lūn-bûn 2015年论文 научни чланак 2015年の論文 vitenskapelig artikkel 2015年论文 2015年論文 мақолаи илмӣ מאמר מדעי научна статия ১৩ ফেব্রুয়ারি ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico scientific article published on 13 February 2015 artykuł naukowy vědecký článek 2015년 논문 artikull shkencor научни чланак επιστημονικό άρθρο 2015年論文 2015年論文 bilimsel makale บทความทางวิทยาศาสตร์ scienca artikolo 2015年论文 bài báo khoa học articol științific 2015年论文 artículo científico publicado en 2015 научная статья artigo científico article scientifique scientific article published on 13 February 2015 artikulong pang-agham 2015年论文 სამეცნიერო სტატია wissenschaftlicher Artikel teaduslik artikkel wetenschappelijk artikel 2015年論文 2015年論文 tieteellinen artikkeli vitskapeleg artikkel 2015年论文 artikel ilmiah naučni članak vedecký článok articolo scientifico наукова стаття, опублікована в лютому 2015 scientific article published on 13 February 2015 videnskabelig artikel artículu científicu espublizáu en 2015 article científic artigo científico مقالة علمية نشرت في 13 فبراير 2015
p:P577
wds:Q41434863-1550D897-0A91-49E9-BC76-C23A244933BA
wdt:P577
2015-02-13T00:00:00Z
p:P2860
wds:Q41434863-F1274612-35C8-4B35-904E-608EB5EA521E wds:Q41434863-FB9A26EC-22D4-45E2-B793-4E411C173648 wds:Q41434863-B7263F76-7C53-433F-B37D-3B41B6A8954B wds:Q41434863-BEEF52B5-1DB4-4270-A9A0-584A4A103DFF wds:Q41434863-CC9973FE-D77D-4030-A2F7-78903CAAC319 wds:Q41434863-DC46F56C-87CA-49F1-9747-3C36B79E6F08 wds:Q41434863-DDED2D8C-7A88-416F-B60D-8D9B3BF6A96D wds:Q41434863-DF91CF79-2FE7-4E80-A859-D83E88D89B2A wds:Q41434863-E871E0AA-F37C-461B-A4B3-840F3CF2ACC0 wds:Q41434863-B2530948-2952-40CE-9589-81B510F6A0E3 wds:Q41434863-B30335FE-6F7A-4B61-8013-74988DF6D8E3 wds:Q41434863-50E5AE30-AF57-49EC-B49B-3974362B102F wds:Q41434863-5284D6C9-B66B-4176-9216-3DBA3C590B2D wds:Q41434863-6DEEDF02-1A87-4BFD-B67F-5F07F1A982C5 wds:Q41434863-6F835D49-F659-4E41-A44D-0ABC3DBA271B wds:Q41434863-152DEC03-E46D-4D30-A165-25AA44EF89FE wds:Q41434863-1EE65B80-01B5-4BF9-B509-9BA58E3DD893 wds:Q41434863-2519CCF2-9DA9-4B7F-AC55-003BFCDA54BA
wdt:P2860
wd:Q37702347 wd:Q37860472 wd:Q44887089 wd:Q24247924 wd:Q36610731 wd:Q36590798 wd:Q36997480 wd:Q53617199 wd:Q33343442 wd:Q38009095 wd:Q37982150 wd:Q43254447 wd:Q33959824 wd:Q44883456 wd:Q44681270 wd:Q43956049 wd:Q46682002 wd:Q37226438
p:P2093
wds:Q41434863-8025636B-E937-4FEB-A536-ADEF999BC896 wds:Q41434863-8B3161B6-433E-4B8E-A832-7EE5FC2D46D2 wds:Q41434863-58979910-5875-4023-8AF5-5E70D4F848BA wds:Q41434863-60A6CD6A-DE00-400E-A398-B5CA960B5E4E wds:Q41434863-40297C61-9B67-4AA6-A1CA-38CDD5150337
wdt:P2093
Robert Tarrell Robert J Karnes Patrick A Cockerill Igor Frank John J Knoedler
rdfs:label
Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer
skos:prefLabel
Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer
schema:name
Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer
p:P1476
wds:Q41434863-FA1DE235-E176-4B2A-AE88-67BAC565CA95
wdt:P1476
Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer
p:P304
wds:Q41434863-8FD26FE0-CCBE-44E7-808E-DB9ECDD4D070
wdt:P304
456-462
p:P31
wds:Q41434863-A4E0B149-5034-4BFE-B73B-9E373C671496
wdt:P31
wd:Q13442814
p:P698
wds:Q41434863-B307CBA1-7AD4-40E1-9A88-8CE6FB2BD704
wdtn:P698
n10:25682834
wdt:P698
25682834
p:P1433
wds:Q41434863-A65E7A1C-D28A-40B0-A185-283EC267018D
wdt:P1433
wd:Q4835773
p:P433
wds:Q41434863-3677FFC7-FDC0-463F-86BF-FD21A4F27F5A
p:P478
wds:Q41434863-DC2CD862-E170-42D1-8B96-3AD699CF5EEE
wdt:P433
3
wdt:P478
117
p:P356
wds:Q41434863-34F7CE21-FEC4-4C56-9B21-B7ADE3A6ECAA
wdtn:P356
n8:BJU.13088
wdt:P356
10.1111/BJU.13088